Inspire Medical Systems Inc. (INSP)
Inspire Medical Systems, Inc. Announces Third Quarter 2025 Financial Results and Updates 2025 Outlook
Vertex Pharmaceuticals (VRTX)
Vertex Reports Third Quarter 2025 Financial Results
Align Technology Inc (ALGN)
Align Technology Opens 2026 Annual Research Program to Advance Orthodontic and Dental Patient Care
Kura Oncology Inc (KURA)
Kura Oncology Receives Second $30 Million Development Milestone Payment in AML Menin Inhibitor Program With Kyowa Kirin
FibroGen Inc (FGEN)
FibroGen to Report Third Quarter 2025 Financial Results
Invivyd Inc (IVVD)
Invivyd to Host Third Quarter 2025 Financial Results and Corporate Update Call on November 6, 2025
Ascendis Pharma (ASND)
3-Year Renal Data in Adults with Hypoparathyroidism Treated with TransCon® PTH (Palopegteriparatide) to Be Shared at Kidney Week 2025
Syndax Pharmaceuticals Inc (SNDX)
Syndax Reports Third Quarter 2025 Financial Results and Provides Business Update
Mind Medicine (MNMD)
MindMed Announces New Employee Inducement Grant
Veradigm Inc (MDRX)
Veradigm Appoints Tehsin Syed as Chief Product and Technology Officer